Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082170 | SCV000114116 | benign | not specified | 2012-11-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082170 | SCV000168557 | benign | not specified | 2013-12-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000082170 | SCV000314260 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV001527240 | SCV001738198 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001527241 | SCV001738199 | benign | Muscular dystrophy-dystroglycanopathy type B5 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001527274 | SCV001738232 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004716936 | SCV005310988 | benign | not provided | criteria provided, single submitter | not provided |